IPP Bureau
Amaris Clinicals clears U.S. FDA audit
By IPP Bureau - September 24, 2021
The company is the Clinical Research Organisation of Caplin Point Laboratories
Aurobindo subsidiary submits MAA for oncology biosimilar
By IPP Bureau - September 23, 2021
CuraTeQ Biologics is on track for filing a second oncology biosimilar
Roche launches three respiratory test panels on Cobas 6800/8800 Systems in CE markets
By IPP Bureau - September 23, 2021
Three new molecular diagnostic test panels for influenza and other common respiratory illnesses can be run together or alone using one patient sample
Thermo Scientific introduces the NanoDrop Eight UV-Vis spectrophotometer
By IPP Bureau - September 23, 2021
The NanoDrop Eight simultaneously evaluates eight samples in 20 seconds or less and the instrument can also measure high-concentration samples of up to 200 absorbance units without dilution
Pfizer and BioNTech receive U.S. FDA EUA for Covid-19 booster
By IPP Bureau - September 23, 2021
Emergency Use Authorisation (EUA) is granted for individuals 65 years of age and older, and individuals ages 18 through 64 within certain high-risk groups
Lonza to expand its drug manufacturing network in Switzerland
By IPP Bureau - September 23, 2021
Lonza, a global manufacturing partner to the pharma, biotech and nutrition industries, has announced it will invest in additional drug product manufacturing capabilities in Switzerland
UFlex joins Alliance in its mission to end plastic waste
By IPP Bureau - September 23, 2021
UFlex has committed close to US $ 10 million towards various initiatives at its overseas and Indian plants to repurpose plastic waste
Endimension receives Rs 2.3 crore in seed funding
By IPP Bureau - September 23, 2021
The startup’s AI platform uses AI algorithms to automatically detect abnormalities and diseases in medical images, reducing patient misdiagnosis and increasing radiologists’ productivity
Indian Pharma Market growth stable in August 2021
By IPP Bureau - September 23, 2021
Post normalisation of high growth months of April and May this year the average IPM growth from June to August this year stood at 15.2 % YoY : Ind-Ra reports
MergerDomo facilitates fundraising for health food and wellness startups
By IPP Bureau - September 22, 2021
The two startups will utilise the capital for business growth including strategic expansion, product development, R&D and technology investments
Terumo India releases stamp to commemorate the centenary of Terumo Corporation
By IPP Bureau - September 22, 2021
Terumo’s first product was the domestically produced, safe, high-quality thermometer. The company has since supported the healthcare ecosystem worldwide
Boehringer Ingelheim acquires Abexxa Biologics to advance its cancer research
By IPP Bureau - September 22, 2021
The addition of Abexxa’s expertise complements Boehringer Ingelheim’s current approaches to the treatment of difficult-to-treat solid cancers and especially those resistant to available immunotherapies
SCHOTT expands tubing capacity in India
By IPP Bureau - September 22, 2021
In India, almost all approved vaccines are packed in FIOLAX glass made by SCHOTT
Trialbee and Castor partner to simplify enrolment to clinical trials globally
By IPP Bureau - September 22, 2021
Industry leaders to increase patient access to clinical research and scale remote enrollment of participants for trial sponsors to promote increased health equity
DCGI approves Ampio Pharma’s Phase II trials to tackle Covid-19 induced respiratory distress
By IPP Bureau - September 22, 2021
Ampion is directly administered by inhalation and it allows the drug to directly target and attenuate inflammation in the lungs